Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid

Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)

(2011) J. M. Scheiman et al.   HEART

Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women

(2010) Shelly L. Gray   ARCHIVES OF INTERNAL MEDICINE

Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice

(2010) Angel Lanas   Expert Opinion On Drug Safety

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

(2010) Farhat V N Din et al.   GUT

Clopidogrel with or without Omeprazole in Coronary Artery Disease

(2010) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of gastroduodenal erosions in patients taking low-dose aspirin

(2009) J. HART et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Proton Pump Inhibitor Use and Enteric Infections

(2009) M Sandra Dial   AMERICAN JOURNAL OF GASTROENTEROLOGY

The pharmacology of esomeprazole and its role in gastric acid related diseases

(2009) Consuelo L Saccar   Expert Opinion on Drug Metabolism & Toxicology

Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions

(2009) Fook–Hong Ng et al.   GASTROENTEROLOGY

The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease

(2009) M. Wurtz et al.   HEART

ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults

(2009) Rita F. Redberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial

(2009) Ali S Taha et al.   LANCET

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks

(2008) A. ROSTOM et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy of Esomeprazole (20 mg Once Daily) for Reducing the Risk of Gastroduodenal Ulcers Associated With Continuous Use of Low-Dose Aspirin

(2008) Neville Yeomans et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

(2008) Deepak L. Bhatt et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY